Microsoft buys eugenics technology from Merck, becomes drug development partner with top global vaccine manufacturer
by Mike Adams
Thursday, February 02, 2012
When you buy Microsoft products, you are now promoting the pharmaceutical industry and its global vaccine agenda. That’s the new reality in which we live, where the world’s largest software company is “in bed” with the world’s largest vaccine pusher.
How so? In 2009, Microsoft purchased a key piece of technology from the drug company Merck, the world’s largest maker of vaccines (which Bill Gates says can help “reduce the global population” by 10 to 15 percent). That technology, as you’ll see below, can conceivably be used to develop eugenics vaccines that target specific races and nationalities with infertility-inducing pharmaceuticals — something that is entirely consistent with Bill Gates’ openly-admitted goal of reducing world population through the use of vaccines (see link to video below).
This gene-targeting vaccine research technology purchased by Microsoft was developed by the company known as Rosetta Biosciences, formerly owned by Merck. Their software is described as a way to “figure out how genes interact with each other, analyze peptides and metabolites, and determine how they relate to gene expression.”